Back
Eat & Beyond Global Holdings Vs. Dyne Therapeutics Industry Stock Comparison
Sell
16
EATS.CX
Eat & Beyond Global Holdings
Last Price:
0.04
Seasonality Move:
-45.42%
Sell
46
DYN
Dyne Therapeutics
Last Price:
30.40
Seasonality Move:
38.02%
Sell
16
Eat & Beyond Global Holdings (EATS.CX)
is a Sell
Is Eat & Beyond Global Holdings a Buy, Sell or Hold?
- The current Eat & Beyond Global Holdings [EATS.CX] share price is $0.04. The Score for EATS.CX is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- EATS.CX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
46
Dyne Therapeutics (DYN)
is a Sell
Is Dyne Therapeutics a Buy, Sell or Hold?
- The current Dyne Therapeutics [DYN] share price is $30.31. The Score for DYN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- DYN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EATS.CX Stock Price Chart
What is Eat & Beyond Global Holdings's stock price today?
-
The Eat & Beyond Global Holdings share price today is $0.04
The current trend is relatively stagnant and EATS.CX is experiencing buying pressure, which is a positive indicator for future bullish movement.
DYN Stock Price Chart
What is Dyne Therapeutics's stock price today?
-
The Dyne Therapeutics share price today is $30.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing selling pressure, which indicates risk of future bearish movement.
EATS.CX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 52.63 | Buy |
| Chaikin Money Flow: | 67500 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.03 - 0.05) | Sell |
| Bollinger Bands (100): | (0.04 - 0.08) | Sell |
DYN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.91 | Sell |
| Relative Strength Index (14 RSI): | 47.11 | Sell |
| Chaikin Money Flow: | -1019710 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.92 - 33.44) | Sell |
| Bollinger Bands (100): | (31.39 - 42.57) | Sell |
EATS.CX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.03 | Buy |
| 20-day SMA: | 0.04 | Buy |
| 50-day SMA: | 0.05 | Sell |
| 200-day SMA: | 0.06 | Sell |
| 8-day EMA: | 0.03 | Buy |
| 20-day EMA: | 0.04 | Buy |
| 50-day EMA: | 0.04 | Sell |
| 200-day EMA: | 0.08 | Sell |
DYN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.77 | Buy |
| 20-day SMA: | 30.55 | Sell |
| 50-day SMA: | 32.55 | Sell |
| 200-day SMA: | 32.11 | Sell |
| 8-day EMA: | 30.26 | Buy |
| 20-day EMA: | 30.69 | Sell |
| 50-day EMA: | 32.85 | Sell |
| 200-day EMA: | 30.82 | Sell |
Eat & Beyond Global Holdings Earnings Growth & EATS.CX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Dyne Therapeutics Earnings Growth & DYN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.10 per share.
Eat & Beyond Global Holdings Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Dyne Therapeutics Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||